EDIT → $2.75 by Jun 26, 2026.

Ticker: **EDIT** Company: **Editas Medicine** Sector: **Biotech / gene editing** Current setup: **post-offering volatility** Bias: **cautious bearish / fade setup if momentum fails** Offering price: **$2.25** Key level: **$3.50 warrant strike** EDIT is on my watchlist after its public offering. On May 26, Editas priced an underwritten public offering of **55,555,556 shares** plus accompanying warrants to purchase another **55,555,556 shares**. The share + warrant package was priced at **$2.25**. Base gross proceeds are expected to be around **$125M** before expenses. …